Evidence map›Paper›PMID 38134231›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Flortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project.

Yi Su, Hillary Protas, Ji Luo, Kewei Chen, Michael L Alosco, Charles H Adler, Laura J Balcer, Charles Bernick, Rhoda Au, Sarah J Banks and 21 more

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Molecular neurodegeneration · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 15 institutions in 1 country.

Yi SuBanner Alzheimer's Institute and Arizona Alzheimer's Consortium, Phoenix, Arizona, USA.
Hillary ProtasBanner Alzheimer's Institute and Arizona Alzheimer's Consortium, Phoenix, Arizona, USA.
Ji LuoBanner Alzheimer's Institute and Arizona Alzheimer's Consortium, Phoenix, Arizona, USA.
Kewei ChenBanner Alzheimer's Institute and Arizona Alzheimer's Consortium, Phoenix, Arizona, USA.
Michael L AloscoDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Charles H AdlerDepartment of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Laura J BalcerDepartments of Neurology, NYU Grossman School of Medicine, New York, New York, USA.
Charles BernickCleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA.
Rhoda AuDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Sarah J BanksDepartments of Neuroscience and Psychiatry, University of California, San Diego, California, USA.
William B BarrDepartments of Neurology, NYU Grossman School of Medicine, New York, New York, USA.
Michael J ColemanDepartments of Psychiatry and Radiology, Psychiatry Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
David W DodickDepartment of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Douglas I KatzDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Kenneth L MarekInstitute for Neurodegenerative Disorders, Invicro, LLC, New Haven, Connecticut, USA.
Michael D McCleanDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Ann C McKeeDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Jesse MezDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Daniel H DaneshvarDepartment of Physical Medicine & Rehabilitation, Massachusetts General Hospital, Spaulding Rehabilitation Hospital, Harvard Medical School, Charlestown, Massachusetts, USA.
Joseph N PalmisanoBoston University Alzheimer's Disease Research Center, Boston University CTE Center, Biostatistics and Epidemiology Data Analytics Center (BEDAC), Boston University School of Public Health, Boston, Massachusetts, USA.
Elaine R PeskindDepartment of Psychiatry and Behavioral Sciences, VA Northwest Mental Illness Research, Education, and Clinical Center, VA Puget Sound Health Care System; University of Washington School of Medicine, Seattle, Washington, USA.
Robert W TurnerDepartment of Clinical Research & Leadership, The George Washington University School of Medicine & Health Sciences, Washington, District of Columbia, USA.
Jennifer V WetheDepartment of Psychiatry and Psychology, Mayo Clinic School of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Gil RabinoviciDepartment of Neurology, University of California San Francisco, San Francisco, California, USA.
Keith JohnsonGordon Center for Medical Imaging, Mass General Research Institute, Harvard Medical School, Boston, Massachusetts, USA.
Yorghos TripodisDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Jeffrey L CummingsDepartment of Brain Health, Chambers-Grundy Center for Transformative Neuroscience, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, USA.
Martha E ShentonDepartments of Psychiatry and Radiology, Psychiatry Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Robert A SternDepartment of Neurology, Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Eric M ReimanBanner Alzheimer's Institute and Arizona Alzheimer's Consortium, Phoenix, Arizona, USA.
DIAGNOSE CTE Research Project Investigators
Boston University · USAlzheimer's Association · USMayo Clinic in Arizona · USBrigham and Women's Hospital · USHarvard University · USNew York University · USEncompass Health (United States)George Washington University · USInvicro (United States) · USUniversity of Arizona · USUniversity of California San Diego · USUniversity of California, San Francisco · USUniversity of Nevada, Las Vegas · USUniversity of Washington · USVA Puget Sound Health Care System · US

Funding

UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOUGLAS R GALASKO · 2019 to 2026
$34.9M
APOE in the Predisposition to, Protection from and Prevention of Alzheimer's DiseaseR01AG069453 · NIA · BANNER HEALTH · PI ASHTON, NICHOLAS, LANGBAUM, JESSICA BROOKE · 2020 to 2025
$27.4M
RL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Ann C. McKee · 2021 to 2026
$25.6M
Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI ALIREZA ATRI · 2021 to 2026
$24.9M
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - ResubmissionP20GM109025 · NIGMS · CLEVELAND CLINIC FOUNDATION · PI JESSICA KIRKLAND CALDWELL · 2015 to 2026
$22.8M
Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk FactorsU01NS093334 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CUMMINGS, JEFFREY L., REIMAN, ERIC MICHAEL · 2016 to 2022
$17.0M
The Contribution of Age-Related Tauopathies to Alzheimer's DiseaseRF1AG062348 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI John Fonda Crary, DENNIS WILLIAM DICKSON · 2023 to 2026
$4.0M
Tracer harmonization for amyloid and tau PET imaging using statistical and deep learning techniquesRF1AG073424 · NIA · BANNER HEALTH · PI SU, YI · 2022 to 2022
$2.3M
NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG072978NIA NIH HHS P30 AG072980NIA NIH HHS R01 AG069453NIA NIH HHS RF1 AG073424NIGMS NIH HHS P20 GM109025NINDS NIH HHS U01 NS093334
6 · The paper itself

Abstract

introductionTau is a key pathology in chronic traumatic encephalopathy (CTE). Here, we report our findings in tau positron emission tomography (PET) measurements from the DIAGNOSE CTE Research Project.

methodWe compare flortaucipir PET measures from 104 former professional players (PRO), 58 former college football players (COL), and 56 same-age men without exposure to repetitive head impacts (RHI) or traumatic brain injury (unexposed [UE]); characterize their associations with RHI exposure; and compare players who did or did not meet diagnostic criteria for traumatic encephalopathy syndrome (TES).

resultsSignificantly elevated flortaucipir uptake was observed in former football players (PRO+COL) in prespecified regions (p < 0.05). Association between regional flortaucipir uptake and estimated cumulative head impact exposure was only observed in the superior frontal region in former players over 60 years old. Flortaucipir PET was not able to differentiate TES groups. DISCUSSION: Additional studies are needed to further understand tau pathology in CTE and other individuals with a history of RHI.

Indexed as

Brain Injuries, TraumaticCarbolinesChronic Traumatic EncephalopathyFootballHumansMaleMiddle AgedPositron-Emission Tomographytau Proteins7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleCarbolinestau ProteinsCTEflortaucipirfootballPETTau

Identifiers

PMID38134231
PMCPMC10984430
OpenAlexW4390099296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.